Prevalence of metabolic syndrome: A comparative analysis in an unselected sample of mediterranean subjects

International Angiology

Volumn 31, Issue 6, 2012, Pages 572-578

  Corrado, E ^a   Rizzo, M ^b   Caccamo, G ^a   Coppola, G ^a   Muratori, I ^b   Tantillo, R ^a   Dell'Oglio, S ^a   Nugara, C ^a   Macaione, F ^a   Novo, G ^a   Alcamo, R ^b   Mignano, A ^a   Ferrara, F ^b   Novo, S ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Atherosclerosis; Inflammation; Insulin resistance; Metabolic syndrome X

Indexed keywords

FIBRINOGEN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NATIONAL HEALTH ORGANIZATION; PREVALENCE; SOUTHERN EUROPE; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; HYPERTENSION; INCIDENCE; ITALY; LIPIDS; LOGISTIC MODELS; METABOLIC SYNDROME X; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; ULTRASONOGRAPHY, DOPPLER, COLOR; WAIST CIRCUMFERENCE;

EID: 84873429050     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Reaven GM, Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
2. Hui WS, Liu Z, Ho SC. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol 2010;25:375-84.
3. Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Preventive Medicine 2010;50:99-105.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8. (Pubitemid 38133916)
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin B et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
7. Alberti KG, Zimmet P, Shaw J, the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
8. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-32.
9. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease. J Am Coll Cardiol 2007;49:2112-9. (Pubitemid 46771048)
10. Caccamo G, Bonura F, Bonura F, Vitale G, Novo G, Evola S et al. Insulin resistance and acute coronary syndrome. Atherosclerosis 2010;211:672-5.
11. Murata M, Ide T. Determination of cholesterol in subnanomolar quantities in biological fluids by high-performance liquid chromatography. J Chromatogr 1992;579:329-33.
12. Montagne P, Laroche P, Cuilliere ML, Varcin P, Duheille J. Microparticle-enhanced nephelometric immunoassay for human C- reactive protein. J Clin Lab Anal 1992;1:24-9.
13. Myers GL, Rifai N, Tracy R, Roberts WL, Alexander RW, Biasucci L et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group. Circulation 2004;110:577-8.
14. Von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:231-7.
15. Imperatore G, Riccardi G, Iovine C, Rivallese A, Vaccaro O. Plasma fibrinogen:a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998;21:649-54. (Pubitemid 28172950)
16. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions:a 5 years follow-up study. Stroke 2006;37:482-6. (Pubitemid 43732010)
17. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall. A direct measurement with ultrasound imaging. Circulation 1986;74:1399-406. (Pubitemid 17189260)
18. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial Hypertension. J Hypertens 2003;21:1011-53.
19. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M et al. Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001;24:683-9. (Pubitemid 32893993)
20. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck Study. Diabetes Care 2003;26:1251-7. (Pubitemid 36929281)
21. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004;21:52-8. (Pubitemid 38168029)
22. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-50. (Pubitemid 39202340)
23. McNeill A, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005;28:385-90. (Pubitemid 40170944)
24. Scuteri A, Najjar SS, Morrell CH, Lakatta EG; Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005;28:882-7. (Pubitemid 40434490)
25. Kahn R. Metabolic syndrome-what is the clinical usefulness? Lancet 2008;371:1892-3.
26. Gale EA. Should we dump the metabolic syndrome? Yes. BMJ 2008;336:640.
27. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middLe-aged men. JAMA 2002;288:2709-16. (Pubitemid 35403784)
28. Ma J, Xu A, Jia C, Liu L, Fu Z, Dong J et al. Associations of fibrinogen with metabolic syndrome in rural Chinese population. J Atheroscler Thromb 2010;17:486-92.
29. Onat A, Ozhan H, Erbilen E, Albayrak S, Küçükdurmaz Z, Can G et al. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol 2009;13:211-7.
30. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004;2:82-104. (Pubitemid 39545406)
31. Coppola G, Rizzo M, Abrignani MG, Corrado E, Di Girolamo A, Braschi A et al. Fibrinogen as a predictor of mortality after acute myocardial infarction:a forty-two-month follow-up study. Ital Heart J 2005;6:315-22.
32. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 2006;37:1004-9. (Pubitemid 44512063)